Evidence map›Paper›PMID 37305128›Full record

ArticleFrontiers in medicine2023

Multicentre study on the accuracy of lung ultrasound in the diagnosis and monitoring of respiratory sequelae in the medium and long term in patients with COVID-19.

Cristina Ramos Hernández, Amara Tilve Gomez, Ana Sánchez Fernández, Rosa Cordovilla, Ana Núñez Ares, Paola Ordoñez Gómez, Aurelio Wangüemert Pérez, Olalla Castro Anón, Jorge González Ramírez, Mar Valdivia Salas and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Cristina Ramos HernándezÁlvaro Cunqueiro Hospital in Vigo, Pneumology Service, NeumoVigo I + i, Southern Galicia Biomedical Research Institute (IISGS), Vigo, Spain.
Amara Tilve GomezÁlvaro Cunqueiro Hospital in Vigo, Radiology Service, Vigo, Spain.
Ana Sánchez FernándezSalamanca University Clinical Hospital, Pneumology Service, Salamanca, Spain.
Rosa CordovillaSalamanca University Clinical Hospital, Pneumology Service, Salamanca, Spain.
Ana Núñez AresAlbacete University Hospital Complex, Pneumology Service, Albacete, Spain.
Paola Ordoñez GómezValencia University Clinical Hospital, Pneumology Service, Valencia, Spain.
Aurelio Wangüemert PérezSan Juan de Dios Hospital in Tenerife, Pneumology Service, Tenerife, Spain.
Olalla Castro AnónLucus Augusti Hospital, Pneumology Service, Lugo, Spain.
Jorge González RamírezLucus Augusti Hospital, Radiology Service, Lugo, Spain.
Mar Valdivia SalasSanta Lucía de Cartagena General University Hospital, Pneumology Service, Cartagena, Spain.
Javier Pérez PallaresSanta Lucía de Cartagena General University Hospital, Pneumology Service, Cartagena, Spain.
Diego Ferrer PargadaMarqués de Valdecilla Hospital, Servicio de Neumología, Pneumology Service, Valencia, Spain.
Fernando Vargas UrsúaÁlvaro Cunqueiro Hospital in Vigo, Pneumology Service, NeumoVigo I + i, Southern Galicia Biomedical Research Institute (IISGS), Vigo, Spain.
Irene Lojo RodriguezÁlvaro Cunqueiro Hospital in Vigo, Pneumology Service, NeumoVigo I + i, Southern Galicia Biomedical Research Institute (IISGS), Vigo, Spain.
Almudena González MontaosÁlvaro Cunqueiro Hospital in Vigo, Pneumology Service, NeumoVigo I + i, Southern Galicia Biomedical Research Institute (IISGS), Vigo, Spain.
Maribel Botana RialÁlvaro Cunqueiro Hospital in Vigo, Pneumology Service, NeumoVigo I + i, Southern Galicia Biomedical Research Institute (IISGS), Vigo, Spain.
Alberto Fernández VillarÁlvaro Cunqueiro Hospital in Vigo, Pneumology Service, NeumoVigo I + i, Southern Galicia Biomedical Research Institute (IISGS), Vigo, Spain.
University Hospital Complex Of Vigo · ESHospital Universitario Lucus Augusti · ESSanta Lucía University General Hospital · ESUniversidad de Salamanca · ESHospital Clínico Universitario de Valencia · ESHospital General Universitario de Albacete · ESMarqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lung ultrasound (LUS) has proven to be a more sensitive tool than radiography (X-ray) to detect alveolar-interstitial involvement in COVID-19 pneumonia. However, its usefulness in the detection of possible pulmonary alterations after overcoming the acute phase of COVID-19 is unknown. In this study we proposed studying the utility of LUS in the medium- and long-term follow-up of a cohort of patients hospitalized with COVID-19 pneumonia. Materials and methods: This was a prospective, multicentre study that included patients, aged over 18 years, at 3 ± 1 and 12 ± 1 months after discharge after treatment for COVID-19 pneumonia. Demographic variables, the disease severity, and analytical, radiographic, and functional clinical details were collected. LUS was performed at each visit and 14 areas were evaluated and classified with a scoring system whose global sum was referred to as the "lung score." Two-dimensional shear wave elastography (2D-SWE) was performed in 2 anterior areas and in 2 posterior areas in a subgroup of patients. The results were compared with high-resolution computed tomography (CT) images reported by an expert radiologist. Results: A total of 233 patients were included, of whom 76 (32.6%) required Intensive Care Unit (ICU) admission; 58 (24.9%) of them were intubated and non-invasive respiratory support was also necessary in 58 cases (24.9%). Compared with the results from CT images, when performed in the medium term, LUS showed a sensitivity (S) of 89.7%, specificity (E) 50%, and an area under the curve (AUC) of 78.8%, while the diagnostic usefulness of X-ray showed an S of 78% and E of 47%. Most of the patients improved in the long-term evaluation, with LUS showing an efficacy with an S of 76% and E of 74%, while the X-ray presented an S of 71% and E of 50%. 2D-SWE data were available in 108 (61.7%) patients, in whom we found a non-significant tendency toward the presentation of a higher shear wave velocity among those who developed interstitial alterations, with a median kPa of 22.76 ± 15.49) versus 19.45 ± 11.39; Conclusion: Lung ultrasound could be implemented as a first-line procedure in the evaluation of interstitial lung sequelae after COVID-19 pneumonia.

Indexed as

COVID-19elastographyLUSSWEultrasound

Identifiers

PMID37305128
PMCPMC10248404
OpenAlexW4378232278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.